Speakers
Expanded Access Coordinator, Early Access Care
Sarah Alummootil joined Early Access Care as an Expanded Access Coordinator in 2017. In this ever adapting pharmaceutical industry, Sarah strives to prioritize the patient during their interaction with each stage of the drug development process. Prior to Early Access Care, Sarah was...
Read More →
Chief Scientific Officer, Early Access Care
RH
Principal Consultant, Pope Woodhead
Regulatory affairs professional with drug development experience spanning 25 years in the consulting/CRO industry and biotech/pharma companies. With a broad technical understanding of pre-clinical, quality, clinical and regulatory procedures. Richard leads Pope Woodhead’s (now Huron...
Read More →
Manager, J McNary Consulting
Jenn McNary is the mother of two young men with a rare disease and a consultant in the biotechnology space with an expertise in caregiver/patient engagement, including bringing the patient voice to drug development and solving barriers to access. Her other activities include serving...
Read More →
Tuesday June 26, 2018 10:30am - 11:30am EDT
Room 206AB
Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA